InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: C504 post# 38330

Thursday, 04/15/2021 12:44:59 PM

Thursday, April 15, 2021 12:44:59 PM

Post# of 44690
Thanks C504 for posting this...

"Translation of the AdVita PR:

14 April 2021
AdVita Lifescience AG is sponsoring a Phase II study in Switzerland entitled:
"Inhaled Aviptadil for the prevention of COVID-19 related Acute Respiratory Distress Syndrome (ARDS) - a randomized, double-blind, placebo controlled, multi center trial."

Swissmedic and the relevant ethics committee have approved the protocol for implementation in several Swiss test centres.
The study medication was produced by a Swiss company and the first patients can be included."!!!

As in , First Patient Dosing/recruitment...